V930
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for V930, covering 2015-02-10 to 2015-03-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Test V930/V932 in Patients With Cancers Expressing Human Epidermal Growth Factor Receptor 2 (HER-2) and/or Carcinoembryonic Antigen (CEA)(V930-003)(COMPLETED) [Phase 1]